$47.90 +0.20 (%) NuVasive Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. NuVasive Focused On Surgeon Support And Showcasing Industry-Leading Products At North American Spine Society 29th Annual Meeting

    Benzinga | Nov. 10, 2014 | 16:25PM EST
  2. Medical-Device Stocks Could Benefit From Tax Repeal

    IBD | Nov. 5, 2014 | 17:42PM EST
  3. NuVasive(R) Demonstrates Expanding EMEA Business at Eurospine 2014 With Surgeon Workshops and ...

    GuruFocus | Oct. 15, 2014 | 12:15PM EST
  4. Fellow orthopedics maker

    IBD | Apr. 24, 2014 | 18:36PM EST
  5. Zimmer To Acquire Biomet; Stock Soars

    IBD | Apr. 24, 2014 | 12:21PM EST
  6. NuVasive Announces $30M Unfavorable Jury Verdict for Use of Trade-Name 'NeuroVision' 8-K

    Benzinga | Apr. 4, 2014 | 06:21AM EST
  7. NuVasive Up After Q4 Beat, Despite Cautious Guidance

    IBD | Mar. 4, 2014 | 12:01PM EST
  8. Ukraine Unrest Sparks Selling But Some Biotechs Firm Up

    IBD | Mar. 3, 2014 | 16:22PM EST
  9. Earnings Scheduled For March 3, 2014

    Benzinga | Mar. 3, 2014 | 04:42AM EST
  10. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 16, 2014 | 10:32AM EST
  11. NuVasive pops to 3-year high

    IBD | Jan. 15, 2014 | 18:46PM EST
  12. Mid-Afternoon Market Update: Markets Nearly Erase Early Year Losses as The ExOne Continues to Drop

    Benzinga | Jan. 15, 2014 | 15:59PM EST
  13. Mid-Day Market Update: Dow Jumps 120 Points; Fastenal Shares Drop On Downbeat Earnings

    Benzinga | Jan. 15, 2014 | 13:44PM EST
  14. NuVasive Preliminary Q4 Sales Beat, Stock Jumps

    IBD | Jan. 15, 2014 | 12:44PM EST
  15. Mid-Morning Market Update: Markets Rise; Bank of America Profit Beats Estimates

    Benzinga | Jan. 15, 2014 | 11:31AM EST
  16. Benzinga's Volume Movers

    Benzinga | Jan. 15, 2014 | 10:33AM EST
  17. Stocks Hitting 52-Week Highs

    Benzinga | Oct. 30, 2013 | 10:23AM EST
  18. UPDATE: Goldman Sachs Downgrades NuVasive as Industry Headwinds, Valuation Pose Downside Risk

    Benzinga | Oct. 14, 2013 | 11:29AM EST
  19. Benzinga's Top Downgrades

    Benzinga | Oct. 14, 2013 | 07:46AM EST
  20. Benzinga's Top Initiations

    Benzinga | Aug. 8, 2013 | 09:18AM EST
  21. Market Wrap For Wednesday, July 31: Stocks Mostly Unchanged Despite Upbeat Data

    Benzinga | Jul. 31, 2013 | 16:23PM EST
  22. Mid-Afternoon Market Update: Fed Leaves Rates Unchanged; Green Dot Rises

    Benzinga | Jul. 31, 2013 | 15:45PM EST
  23. Mid-Afternoon Market Update: NuVasive Rises While EXCO Resourced Drops

    Benzinga | Jan. 9, 2013 | 08:52AM EST
  24. Mid-Day Market Update: Markets Remain Up, Dynavax Continues Rally

    Benzinga | Jan. 9, 2013 | 07:19AM EST
  25. Benzinga's Top Upgrades

    Benzinga | Jan. 9, 2013 | 00:11AM EST
  26. NuVasive Announces First Patient in the United States Treated With the PCM Cervical Disc Following FDA Approval

    Benzinga | Dec. 20, 2012 | 07:40AM EST
  27. NuVasive(R) Announces Release of $62.5M From Escrow Following Appeals Court Victory

    Benzinga | Dec. 13, 2012 | 09:50AM EST
  28. NuVasive to Release $62.5M from Escrow Following Appeals Court Win

    Benzinga | Dec. 13, 2012 | 09:49AM EST
  29. Covidien Stock Rises After Earnings Beat Estimates

    IBD | Nov. 9, 2012 | 03:36AM EST
  30. NuVasive Announces PMA Approval of the PCM(R) Cervical Disc System

    Benzinga | Oct. 26, 2012 | 06:02AM EST
  31. NuVasive Inc. Reports Operating Results (10-Q)

    GuruFocus | Oct. 25, 2012 | 03:02AM EST
  32. Benzinga's Top Downgrades

    Benzinga | Oct. 25, 2012 | 01:27AM EST
  33. UPDATE: Goldman Sachs Reduces PT to $16 on NuVasive on Sales Outlook

    Benzinga | Oct. 24, 2012 | 08:22AM EST
  34. Intuitive Surgical Stock Rebounds From Q3 Dive

    IBD | Oct. 17, 2012 | 05:09AM EST
  35. Intuitive Surgical Stock Upgraded Ahead Of Q3 Report

    IBD | Oct. 15, 2012 | 05:12AM EST
  36. FDA Ruling on Artificial Disc Boosts Globus Medical

    IBD | Oct. 10, 2012 | 07:29AM EST
  37. The Hell With NuVasive Stock: Get Hired by One of its Competitors at $1M

    YCharts | Oct. 5, 2012 | 10:39AM EST
  38. Stocks Post Gains after Positive Data with Bank of America (BAC) and Alcoa (AA) on the Move

    MarketIntelligenceCenter | Oct. 4, 2012 | 16:21PM EST
  39. Nuvasive (NUVA) Drops 33% on Weak Q3 Revenue

    MarketIntelligenceCenter | Oct. 4, 2012 | 10:31AM EST
  40. Benzinga Mid-Afternoon Market Update

    Benzinga | Oct. 4, 2012 | 09:52AM EST
  41. Stock Futures Point to Higher Open Ahead of Data with Facebook (FB) and Hewlett-Packard (HPQ) on the move

    MarketIntelligenceCenter | Oct. 4, 2012 | 08:28AM EST
  42. UPDATE: BMO Capital Markets Downgrades NuVasive to Underperform on Outlook

    Benzinga | Oct. 4, 2012 | 06:45AM EST
  43. Benzinga Mid-Morning Market Update

    Benzinga | Oct. 4, 2012 | 04:22AM EST
  44. US Stock Futures Up; Jobless Claims, ECB Meeting In Focus

    Benzinga | Oct. 4, 2012 | 00:09AM EST
  45. Stocks To Watch For October 4, 2012

    Benzinga | Oct. 3, 2012 | 20:06PM EST
  46. Nuvasive

    IBD | Oct. 3, 2012 | 12:49PM EST
  47. NuVasive Cuts Q3 Prelim Revenue, Forecast $147M

    Benzinga | Oct. 3, 2012 | 10:06AM EST
  48. NuVasive Inc. Reports Operating Results (10-Q)

    GuruFocus | Jul. 26, 2012 | 08:13AM EST
  49. Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying

    Benzinga | Jun. 26, 2012 | 04:13AM EST
  50. Analyst Upgrades: NUVA, ONXX, and SKUL

    SchaeffersResearch | Jun. 21, 2012 | 09:31AM EST
Trading Center